Gideon Bollag Selected Research

Sarcoma (Soft Tissue Sarcoma)

4/2013	Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.
8/2010	Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gideon Bollag Research Topics

Disease

42	Neoplasms (Cancer) 09/2023 - 12/2003
17	Melanoma (Melanoma, Malignant) 01/2018 - 02/2008
3	Leukemia 01/2023 - 12/2013
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2013
3	Colorectal Neoplasms (Colorectal Cancer) 02/2013 - 05/2011
2	Disease Progression 09/2021 - 01/2021
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021 - 05/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 07/2004
2	Lung Neoplasms (Lung Cancer) 11/2016 - 02/2014
2	Sarcoma (Soft Tissue Sarcoma) 04/2013 - 08/2010
2	Thyroid Neoplasms (Thyroid Cancer) 01/2010 - 12/2009
1	Ovarian Neoplasms (Ovarian Cancer) 09/2023
1	Ovarian Epithelial Carcinoma 09/2023
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2022
1	Plexiform Neurofibroma 11/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Colonic Neoplasms (Colon Cancer) 02/2016
1	Giant Cell Tumors (Giant Cell Tumor) 07/2015
1	Giant Cell Tumor of Tendon Sheath 07/2015
1	Thymoma (Thymic Carcinoma) 02/2015
1	Neurofibroma 01/2013
1	Keratoacanthoma 01/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012
1	Carcinogenesis 01/2012
1	Papillary Thyroid Cancer 12/2011
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 11/2011
1	Fibrosis (Cirrhosis) 11/2011
1	Cysts 11/2011
1	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2011
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Body Weight (Weight, Body) 01/2009

Drug/Important Bio-Agent (IBA)

15	VemurafenibIBA 01/2018 - 01/2010
12	Phosphotransferases (Kinase)IBA 09/2021 - 10/2004
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022 - 01/2010
8	pexidartinibIBA 01/2021 - 01/2013
6	Macrophage Colony-Stimulating FactorIBA 01/2019 - 05/2013
6	PLX 4720IBA 03/2016 - 02/2008
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 07/2010
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2008
4	ras ProteinsIBA 02/2016 - 08/2006
4	Proto-Oncogene Proteins B-rafIBA 08/2015 - 09/2010
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011 - 10/2004
3	PLX51107IBA 01/2021 - 01/2018
3	PLX8394IBA 01/2019 - 11/2016
3	Mitogen-Activated Protein KinasesIBA 11/2016 - 10/2004
3	Protein Kinases (Protein Kinase)IBA 11/2016 - 02/2008
2	fms-Like Tyrosine Kinase 3IBA 01/2023 - 01/2020
2	AndrogensIBA 01/2019 - 03/2015
2	Amino Acids FDA Link 02/2016 - 08/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2015 - 12/2008
2	CytokinesIBA 03/2015 - 05/2013
2	Sorafenib (BAY 43-9006)FDA Link 11/2013 - 10/2004
2	Codon (Codons)IBA 02/2012 - 07/2010
2	raf KinasesIBA 11/2011 - 10/2004
2	Adenosine Triphosphate (ATP)IBA 01/2010 - 12/2009
2	Cytostatic AgentsIBA 01/2010 - 12/2009
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2005 - 07/2004
1	Carboplatin (JM8)FDA LinkGeneric 09/2023
1	PlatinumIBA 09/2023
1	Mutant Proteins (Protein, Mutant)IBA 01/2023
1	AZD 6244IBA 11/2022
1	Sunitinib (Sutent)FDA Link 09/2021
1	Tyrosine (L-Tyrosine)FDA Link 09/2021
1	Cyclin D3IBA 01/2021
1	Imatinib Mesylate (Gleevec)FDA Link 05/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	CytosineIBA 01/2018
1	tubulin-specific chaperone CIBA 08/2015
1	JNK Mitogen-Activated Protein KinasesIBA 08/2015
1	quizartinibIBA 06/2015
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 05/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2015
1	ABT-737IBA 02/2015
1	MK 2206IBA 02/2015
1	Type C PhospholipasesIBA 12/2013
1	Cytokine Receptors (Cytokine Receptor)IBA 12/2013
1	Conditioned Culture MediaIBA 05/2013
1	Cell Surface ReceptorsIBA 04/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2013
1	MethyltransferasesIBA 02/2013
1	Doxycycline (Periostat)FDA LinkGeneric 12/2011
1	Oncogene Proteins (Oncogene Protein)IBA 12/2011
1	CollagenIBA 11/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011
1	Calcibiotic Root Canal SealerIBA 05/2011
1	ErbB Receptors (EGF Receptor)IBA 08/2010
1	MitogensIBA 07/2010
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	CholesterolIBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009

Therapy/Procedure

14	Therapeutics 11/2022 - 02/2010
2	Drug Therapy (Chemotherapy) 01/2019 - 02/2010
1	Cell Transplantation 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Castration 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2014
1	Radiotherapy 05/2013